MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand ...
MILFORD, Mass., Oct. 10, 2024 /PRNewswire/ -- Waters Corporation (WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence ...
Waters Corporation WAT has been continuously making new enhancements to gain momentum in the Liquid Chromatography Mass Spectrometry (LC-MS) market. This is evident from the fact that the company ...
The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform "The BioAccord LC-MS System was designed to optimize performance ...
Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced that the Waters ® ACQUITY UPLC ® I-Class IVD/Xevo ® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I ...
Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly ...